Immunoprecise Antibodies shares owned by CIBC World Markets
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by CIBC World Markets
from 13F filings
Historical chart of CIBC World Markets investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunoprecise Antibodies by CIBC World Markets
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $26k | 41k | 0.63 |
| 2024-06-30 | $42k | 41k | 1.02 |
| 2024-03-31 | $63k | 41k | 1.53 |
| 2023-09-30 | $76k | 42k | 1.82 |
| 2023-06-30 | $126k | 42k | 2.97 |
| 2023-03-31 | $118k | 42k | 2.78 |
| 2022-12-31 | $251k | 47k | 5.29 |
| 2022-09-30 | $189k | 47k | 3.99 |
| 2022-06-30 | $183k | 47k | 3.86 |